Skip to main content
Top
Published in: Clinical and Translational Oncology 6/2011

01-06-2011 | Research Articles

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

Authors: Toshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Hisae Iinuma, Tsuyoshi Konishi, Hisanaga Horie, Hiroki Ikeuchi, Kiyoshi Eshima, Tetsuichiro Muto

Published in: Clinical and Translational Oncology | Issue 6/2011

Login to get access
Metadata
Title
Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients
Authors
Toshiaki Watanabe
Takashi Kobunai
Yoko Yamamoto
Keiji Matsuda
Soichiro Ishihara
Keijiro Nozawa
Hisae Iinuma
Tsuyoshi Konishi
Hisanaga Horie
Hiroki Ikeuchi
Kiyoshi Eshima
Tetsuichiro Muto
Publication date
01-06-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0676-z

Other articles of this Issue 6/2011

Clinical and Translational Oncology 6/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine